AzTrials
AzTrials

Total Knee ArthroplastyKAROSNCT02426190

Knee Arthroplasty Rehabilitation Outcomes Study

A study testing Anti-gravity treadmill, PENS - neuro-muscular stimulation and Anti-gravity treadmill & PENS - neuro-muscular stimulation in people with Total Knee Arthroplasty and Rehabilitation, run by MedStar National Rehabilitation Network at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of the KAROS study is to compare rehabilitation outcomes between 3 proposed protocols and a current standard of care protocol for the purpose of identifying better practice for outpatient rehabilitation among patients with single total knee replacement. Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Total Knee Arthroplasty, Rehabilitation
What is being tested?
Anti-gravity treadmill, PENS - neuro-muscular stimulation and Anti-gravity treadmill & PENS - neuro-muscular stimulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
386 participants
Where
1 siteUnited States
Study dates
Oct 2014to 31 Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who undergo an elective single total knee arthroplasty and initiate their outpatient rehabilitation therapy within 3 weeks after surgery.
  • Patients who are 40 years old or older.
  • Patients who weight less than 320 lb to accommodate the weight limit to use the anti-gravity treadmill.

Who cannot join

  • Patients who had any lower extremity joint replacement less than 1 year prior the current total knee replacement.
  • Patients who are pregnant or may be pregnant.
  • Patients who have a medical history of neurologic disorders.
  • Patients who have received more than 2 weeks of other formats of rehabilitation prior their outpatient rehabilitation program.
  • Patients who received any cancer treatment in the past year prior the current surgery.
  • Patients who have uncontrolled cardiovascular hypertension.
  • Patients who have cardiac demand pacemakers and/or implanted defibrillators.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • MedStar National Rehabilitation Network

    Washington D.C., District of Columbia, 20010

Other trials in United States

About this study

The objective of the KAROS study is to compare rehabilitation outcomes between 3 proposed protocols and a current standard of care protocol for the purpose of identifying better practice for outpatient rehabilitation among patients with single total knee replacement. The 3 advanced protocols involve use of an anti-gravity treadmill and/or the patterned electrical neuromuscular stimulation (PENS). Both medical modalities have been cleared by the FDA to be used in medical rehabilitation, including total knee replacement.

Being tested
Anti-gravity treadmill, PENS - neuro-muscular stimulation, Anti-gravity treadmill & PENS - neuro-muscular stimulation, Recumbent or Nu-step bike

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Anti-gravity treadmillOther

    The intervention is to ask study participants to ambulate using an anti-gravity treadmill that integrates patented, NASA Differential Air Pressure (DAP) technology -- a precise air calibration system -- to uniformly reduce gravitational load and body weight during the warm-up phase of an outpatient physical therapy following a single total knee replacement.

  • PENS - neuro-muscular stimulationOther

    The intervention is to ask study participants to warm up using Patterned Electrical Neuromuscular Stimulation (PENS) - that closely replicates the body's normal muscle and nerve firing patterns -- on his/her surgical leg in conjunction with a recumbent bike or a Nu-step bike during the warm-up phase of an outpatient physical therapy following a single total knee replacement.

  • Anti-gravity treadmill & PENS - neuro-muscular stimulationOther

    The intervention is to ask study participants to ambulate using an anti-gravity treadmill in conjunction with use of Patterned Electrical Neuromuscular Stimulation (PENS) during the warm-up phase of an outpatient physical therapy following a single total knee replacement.

  • Recumbent or Nu-step bikeOther

    This is the active comparator of the trial that participants are asked to use either a recumbent or Nu-step bike normally seen in an outpatient physical therapy clinic to warm-up during a physical therapy session following a single total knee replacement.

Study groups in NCT02426190
Study groupRoleWhat they receive
Arm 1Active comparatorPatients in Arm 1 receive standard of care rehabilitation protocol using a recumbent or Nu-step bike during warm-up, followed by individualized therapeutic exercise, and cool-down protocols. The warm-up phase in the study refers to therapeutic exercise. The therapeutic exercise aims to condition and prepare patients for subsequent functional or therapeutic activities. The active comparator (Arm 1) is to ask participants to use modalities, such as a recumbent bike or a Nu-step bike during the warm-up phase of an outpatient physical therapy following a single total knee replacement.
Receives: Other: Recumbent or Nu-step bike
Arm 2ExperimentalPatients in Arm 2 will use an anti-gravity treadmill (AlterG) during warm-up, followed by individualized therapeutic exercise and cool-down protocols.
Receives: Other: Anti-gravity treadmill
Arm 3ExperimentalPatients in Arm 3 will use a recumbent or Nu-step bike along with the PENS neuromuscular stimulation modality during warm-up, followed by individualized therapeutic exercise and cool-down protocols.
Receives: Other: PENS - neuro-muscular stimulation
Arm 4ExperimentalPatients in Arm 4 will use both an anti-gravity treadmill (AlterG) and the PENS neuromuscular stimulation modality during warm-up, followed by individualized therapeutic exercise and cool-down protocols.
Receives: Other: Anti-gravity treadmill & PENS - neuro-muscular stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. AM-PAC (Activity Measure for Post Acute Care) Basic Mobility score: Baseline

    The primary outcome measure is the AM-PAC Basic Mobility score. AM-PAC is a patient-reported instrument to measure functional level in 3 domains: basic mobility, daily activity, and applied cognition. For the purpose of the study, only the basic mobility domain was measured. Using item-response theory, the AM-PAC program selects the most representative questions from its extensive item bank to ask when measuring a patient's functional level. This study used the AM-PAC basic mobility paper short form designed for outpatient settings. The short-form consists of 18 questions and produces a raw score (18 to 72) transformed into a score ranging from 29.41 to 80.30 based on item-degree of difficulty. Higher transformed scores denote higher functional mobility: 34 - 51.9 = limited indoor mobility; 52 - 65.9 = enhanced indoor mobility; 66 and above = outdoor mobility.

    Measured: Baseline

  2. AM-PAC (Activity Measure for Post Acute Care) Basic Mobility score: Discharge from outpatient rehabilitation

    The primary outcome measure is the AM-PAC Basic Mobility score upon discharge from outpatient therapy. AM-PAC is a patient-reported instrument to measure functional level in 3 domains: basic mobility, daily activity, and applied cognition. For the purpose of the study, only the basic mobility domain was measured. Using item-response theory, the AM-PAC program selects the most representative questions from its extensive item bank to ask when measuring a patient's functional level. This study used the AM-PAC basic mobility paper short form designed for outpatient settings. The short-form consists of 18 questions and produces a raw score (18 to 72) transformed into a score ranging from 29.41 to 80.30 based on item-degree of difficulty. Higher transformed scores denote higher functional mobility: 34 - 51.9 = limited indoor mobility; 52 - 65.9 = enhanced indoor mobility; 66 and above = outdoor mobility.

    Measured: Discharge from outpatient rehabilitation (on average 2 months from baseline)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2015 (estimated)
  2. Study startOct 2014
  3. Primary completionDec 2017
  4. Study completion31 Dec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
386 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02426190
Sponsor's protocol ID
2012-347
Acronym
KAROS
Status last verified
Apr 2019
First submitted
8 Apr 2015
Last updated
16 Apr 2019
Results posted
No
Data monitoring committee
No

Publications

  • Hsieh CJ, DeJong G, Vita M, Zeymo A, Desale S. Effect of Outpatient Rehabilitation on Functional Mobility After Single Total Knee Arthroplasty: A Randomized Clinical Trial. JAMA Netw Open. 2020 Sep 1;3(9):e2016571. doi: 10.1001/jamanetworkopen.2020.16571.

    PubMed 32940679
  • DeJong G, Hsieh CJ, Vita MT, Zeymo A, Boucher HR, Thakkar SC. Innovative Devices Did Not Provide Superior Total Knee Arthroplasty Outcomes in Post-Operative Rehabilitation: Results From a Four-Arm Randomized Clinical Trial. J Arthroplasty. 2020 Aug;35(8):2054-2065. doi: 10.1016/j.arth.2020.03.048. Epub 2020 Apr 2.

    PubMed 32360105

Questions about this trial

What is this clinical trial studying?

A study testing Anti-gravity treadmill, PENS - neuro-muscular stimulation and Anti-gravity treadmill & PENS - neuro-muscular stimulation in people with Total Knee Arthroplasty and Rehabilitation, run by MedStar National Rehabilitation Network at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

AM-PAC (Activity Measure for Post Acute Care) Basic Mobility score: Baseline (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02426190, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in